Conferences
Christopher Kata and the TrialStat team are attend this years “SoCalBio 25th Annual Conference” meeting on October 25th through the 26th in Long Beach, California. If you’re attending be sure to to reach out to Christopher to schedule a one on meeting! We’re looking forward to meeting with you and providing live, personalized demonstrations of…
Read More
Christopher Kata and the TrialStat team are attend this years “Octane Medical Innovations Forum” meeting on October 25th through the 26th in Irvine, California. If you’re attending be sure to to reach out to Christopher to schedule a one on meeting! We’re looking forward to meeting with you and providing live, personalized demonstrations of our…
Read More
Christopher Kata and the TrialStat team are exhibiting at this years DPHARM meeting on September 20th through the 22nd in booth #116. If you’re attending be sure to to reach out to Christopher to schedule a one on meeting or just drop by booth #116 at your convenience! We’re looking forward to providing live, personalized…
Read More
Christopher Kata and the TrialStat team are exhibiting at this years DPHARM meeting on September 20th through the 22nd in booth #57. If you’re attending be sure to to reach out to Christopher to schedule a one on meeting or just drop by booth #57 at your convenience! We’re looking forward to providing live, personalized…
Read More
Excerpt from the Press Release: As we begin a new year, a singular message rings true across all pockets of the life science industry – we must ‘do more with less.’ This message was echoed during the recent JP Morgan Healthcare Conference and will continue to resonate throughout the year. The macroeconomic conditions facing our…
Read More
Excerpt from the Press Release: FREMONT, CA, Jan. 19, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Dr. Keith McBurnett, Professor of Psychiatry at the University of California San Francisco, presented the results of the…
Read More
Meet with Christopher Kata, Director of Sales & Marketing February 6th – 9th, 2023 at the SCOPE Summit for Clinical Operations Executives in Orlando, Florida. Christopher and the TrialStat team are exhibiting in booth # 906. Christopher Kata, Director of Sales & Marketing905 [email protected] Event: SCOPE – Summit for Clinical Operations Executives When: February 6th…
Read More
-Participants with SR-aGVHD disease achieved an ORR of 67% and CR of 17% as measured by best response- -Participants with TR-aGVHD (11 of 12 concomitant ruxolitinib) achieved an ORR of 67% and CR of 25% at Day 28- -Median survival benefits in TR-aGVHD participants compare favorably to historical controlsneihulizumab was well tolerated, with similar safety…
Read More
Meet in person with Christopher Kata during CPHI in Frankfurt, on November 1st to 3rd. If you’re attending be sure to reach out to Christopher to schedule a one on meeting! Each year CPHI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the global…
Read More
Christopher Kata is once again attending the CRAC – Future Considerations for Conducting Clinical Trials November 17th at the Markland Wood Golf Club. If you’re attending be sure to reach out to Christopher to schedule a one on meeting or search him out at the meeting! Christopher will be delivering a presentation titled “How To…
Read More